Osaic Holdings
ONCT

Osaic Holdings’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Osaic Holdings’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-150
Closed -$198 – 7774
2024
Q3 		$198 Hold
150
– – ﹤0.01% 7178
2024
Q2 		$1.14K Sell
150
-137
-48% -$1.18K ﹤0.01% 6775
2024
Q1 		$2.58K Sell
287
-156
-35% -$1.37K ﹤0.01% 6376
2023
Q4 		$4.75K Sell
443
-180
-29% -$1.3K ﹤0.01% 6201
2023
Q3 		$3.73K Buy
623
+50
+9% +$352 ﹤0.01% 6394
2023
Q2 		$3.95K Sell
573
-415
-42% -$2.74K ﹤0.01% 6413
2023
Q1 		$15.5K Buy
988
+8
+0.8% +$157 ﹤0.01% 5713
2022
Q4 		$19K Sell
980
-49
-5% -$975 ﹤0.01% 5614
2022
Q3 		$19K Sell
1,029
-100
-9% -$2.15K ﹤0.01% 5630
2022
Q2 		$25K Sell
1,129
-50
-4% -$1.11K ﹤0.01% 5471
2022
Q1 		$32K Buy
1,179
+87
+8% +$3.17K ﹤0.01% 5408
2021
Q4 		$50K Sell
1,092
-312
-22% -$21K ﹤0.01% 5152
2021
Q3 		$117K Buy
1,404
+131
+10% +$10.8K ﹤0.01% 4397
2021
Q2 		$121K Buy
1,273
+908
+249% +$108K ﹤0.01% 4323
2021
Q1 		$61K Buy
365
+115
+46% +$15.2K ﹤0.01% 4741
2020
Q4 		$25K Buy
+250
New +$15.8K ﹤0.01% 5027

Other funds holding ONCT

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Osaic Holdings's ONCT Position: Q4 2024 in Review

Osaic Holdings sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2024, closing a stake of 150 shares — an estimated $198 sold.

Osaic Holdings first reported a position in ONCT in Q4 2020 and held it in 16 quarters. The position peaked at $121K in Q2 2021. 4 funds tracked by Wall St. Rank hold ONCT as of Q4 2024.

  • Osaic Holdings reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 150 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $198.
  • Osaic Holdings first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2020 and held it in 16 quarters.
  • Osaic Holdings's Oncternal Therapeutics, Inc. Common Stock position peaked at $121K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.